Pacific Capital Partners’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,000
Closed -$748K 61
2024
Q4
$748K Buy
12,000
+2,218
+23% +$206K 0.44% 46
2024
Q3
$1.54M Sell
9,782
-1,774
-15% -$273K 0.9% 33
2024
Q2
$1.74M Sell
11,556
-2,817
-20% -$338K 1.15% 27
2024
Q1
$1.06M Buy
14,373
+1,820
+14% +$150K 0.7% 42
2023
Q4
$991K Buy
12,553
+1,656
+15% +$99.9K 0.75% 37
2023
Q3
$597K Buy
+10,897
New +$784K 0.36% 50

Other funds holding TMDX

Pacific Capital Partners's TMDX Position: Q1 2025 in Review

Pacific Capital Partners sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 12,000 shares — an estimated $748K sold.

Pacific Capital Partners first reported a position in TMDX in Q3 2023 and held it in 6 quarters. The position peaked at $1.74M in Q2 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Pacific Capital Partners reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Pacific Capital Partners sold 12,000 Transmedics shares in Q1 2025, an estimated $748K.
  • Pacific Capital Partners first reported a position in Transmedics in Q3 2023 and held it in 6 quarters.
  • Pacific Capital Partners's Transmedics position peaked at $1.74M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Pacific Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.